Calquence Tablet, Film Coated
Product Images NDC 0310-4513

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Calquence (NDC 0310-4513). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Astrazeneca Pharmaceuticals Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg_60_tablet_bottle (100mg 60 Tablets Bottle)

CALQUENCE® is a prescription medication available in the form of tablets with the NDC code 0310-3512-60. It contains acalabrutinib as the active ingredient. The medication is manufactured in Switzerland for AstraZeneca Pharmaceuticals LP based in Wilmington, DE 19850, and by AstraZeneca AB based in SE-151 85 Sodertalie, Sweden. The tablets are not to be chewed, crushed, dissolved, or cut.*

FDA Label Image

Chemical_structure (Chemical Structure)

FDA Label Image

Figure_1 (Figure 1)

FDA Label Image

Figure_2 (Figure 2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.